Real-time enrollment status for this non-small cell lung cancer (nsclc) clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 11:46 PM UTC
| NCT Number | NCT07288177 |
| Recruiting Status | Recruiting |
| Condition | Non-small Cell Lung Cancer (NSCLC) |
| Phase | PHASE2 |
| Target Enrollment | 240 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Genmab |
| Last Updated on CT.gov | August 26, 2026 (3 days ago) |
As of August 29, 2026: Clinical trial NCT07288177 is currently recruiting participants. This phase2 study for non-small cell lung cancer (nsclc) is actively seeking new participants at 19 locations across the United States. The study is sponsored by Genmab. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07288177 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07288177 was last updated 3 days ago (August 26, 2026). HelloStudys verifies this status automatically.